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Identification of disease-causing genes among a large number of candidates is a fundamental challenge in human disease stud-
ies. However, it is still time-consuming and laborious to determine the real disease-causing genes by biological experiments. 
With the advances of the high-throughput techniques, a large number of protein-protein interactions have been produced. 
Therefore, to address this issue, several methods based on protein interaction network have been proposed. In this paper, we 
propose a shortest path-based algorithm, named SPranker, to prioritize disease-causing genes in protein interaction networks. 
Considering the fact that diseases with similar phenotypes are generally caused by functionally related genes, we further pro-
pose an improved algorithm SPGOranker by integrating the semantic similarity of gene ontology (GO) annotations. 
SPGOranker not only considers the topological similarity between protein pairs in a protein interaction network but also takes 
their functional similarity into account. The proposed algorithms SPranker and SPGOranker were applied to 1598 known or-
phan disease-causing genes from 172 orphan diseases and compared with three state-of-the-art approaches, ICN, VS and RWR. 
The experimental results show that SPranker and SPGOranker outperform ICN, VS, and RWR for the prioritization of orphan 
disease-causing genes. Importantly, for the case study of severe combined immunodeficiency, SPranker and SPGOranker pre-
dict several novel causal genes. 
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An orphan disease (OD) is the disease that affects only a 
small percentage of the population, which is defined as a 
disease that affects fewer than 200000 inhabitants in the 
USA [1]. There are about 8000 ODs and most of which are 
genetic, and thus are present throughout the person’s entire 
life, even if symptoms do not immediately appear [2,3]. 
More important, most ODs affect children at a very early 
age and about 30% of children with ODs will die before 
reaching their fifth birthday. 
To find disease-causing genes (or genes involved in a bi-
ological process), researchers usually use the traditional 
positional cloning approaches or high-throughput genomic 
technologies to identify hundreds or even thousands of can-
didate genes [4]. However, it is too time-consuming and 
laborious to validate these candidate genes one by one 
through biological experiments [5,6]. Fortunately, the hu-
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man genome project has been completed and this project 
has achieved great success, at the same time, the develop-
ment of high-throughput approaches has provided a large 
number of protein-protein interactions, which make it pos-
sible for us to study life activity at the network level [79]. 
Many network-based methods have been proposed to pre-
dict protein functions, identify essential proteins, and detect 
disease-causing genes and related complexes or pathways 
[1021]. It also has been shown that genes associated with 
the similar phenotypes tend to share the common molecular 
signatures including similar expression profiles, participa-
tion in the same biological processes, pathways, or com-
plexes [2224]. Moreover, the research of human disease 
and the experiment of model organisms show that direct and 
indirect interactions occurred between protein pairs may be 
responsible for similar disease phenotypes [2527]. These 
researches motivate us to predict disease-causing genes by 
using protein interaction networks.   
In recent years, many network-based computational ap-
proaches have been proposed for prioritizing candidate dis-
ease genes [2836]. Generally, the prioritization approaches 
can be grouped into two main categories: (i) global methods 
which model the information flow in the cell to assess the 
proximity and connectivity between known disease genes 
and candidate genes, such as PRIoritizatioN and Complex 
Elucidation (PRINCE [32]), Random Walk with Restart 
(RWR [33]), and PageRank with Priors (PRP [34]), and (ii) 
localized methods which predict new disease candidates by 
counting the direct interacting genes or computing the 
shortest paths between known disease genes and candidate 
genes, such as Interconnectedness (ICN [35]), and Vertex 
similarity-based frameworks (VS [36]).  
In addition, some typical graph partitioning methods and 
clustering approaches, such as GS [37], MCL [38], VI-Cut 
[39], IPCA [40], MSCF [41], HC-PIN [42], and their im-
proved algorithms, can also be used to discover candidate 
disease-related genes.  
Although great progress has been made on the net-
work-based methods, it is still a challenging task to identify 
disease-causing genes based on protein interaction network, 
for there are still a large number of false-positives or nega-
tives existing in the current available protein-protein inter-
action data [43]. To reduce the effect of the false positives, 
different types of biological data related to proteins, such as 
gene expression profiles [4448], orthology information 
[49], gene ontology (GO) annotations, have been used in the 
identification of protein complexes, discovery of essential 
proteins, prediction of protein functions, or the detection of 
disease-causing genes.  
Based on an overall analysis of ‘guilt-by-association’ 
principle and the effectiveness of local network information, 
we proposed a localized algorithm, SPranker, to prioritize 
ODs-causing genes. To reduce the effect of the false posi-
tives in protein interaction network, we further integrated 
GO annotations to improve our proposed algorithm 
SPranker. The improved algorithm, named SPGOranker, 
prioritizes the disease-causing candidates by combining GO 
similarity of the candidate genes with their topological sim-
ilarity. The proposed algorithms SPranker and SPGOranker 
were tested on the 172 ODs with at least five known causal 
genes (from Orphanet database [50]). In our experiments, 
the leave-one-out cross-validation was used to validate the 
effectiveness of the proposed algorithms. Based on the 
leave-one-out cross-validation, the proposed algorithm 
SPranker was shown to outperform three other state-of-the- 
art algorithms: RWR [33], ICN [35], and VS [36]. The 
combination of GO annotations contributed to the prioriti-
zation of disease-causing genes and SPGOranker was 
shown to perform better than SPranker. Moreover, SPranker 
and SPGOranker were applied to predict potential novel 
candidate genes by prioritization of the immediate neigh-
bors of known OD genes in the human protein interaction 
network. 
1  Methods 
1.1  SPranker: shortest path based algorithm to priori-
tize disease-causing genes 
The common assumption of network-based disease-causing 
gene prioritization methods is that genes that are physically 
or functionally close to each other tend to be involved in the 
same biological pathways and have similar effects on phe-
notypes, which is known as ‘guilt-by-association’ principle 
[51]. Hence, the most important thing is how to measure the 
similarities between the known disease genes and candidate 
genes in a protein interaction network. In this paper, we use 
two different strategies to calculate the similarity between 
proteins: one is for the connected protein pairs and the other 
is for the proteins which do not have edges connecting them 
directly.  
To describe the proposed algorithm easily, we first give 
some necessary definitions. A protein interaction network is 
described as an undirected graph G=(V,E,W), where V rep-
resents the set of proteins, an edge (vi,vj)∈E denotes that 
the protein vi and the protein vj connect with each other in 
the network, and w(vi,vj)∈W represents the weight of the 
edge (vi,vj). For an unweighted graph G, w(vi,vj)=1 if and 
only if the protein vi and the protein vj connect each other in 
the graph G, otherwise w(vi,vj)=0. Given a protein v∈V, its 
neighbors are the proteins which interact with it in the net-
work. The set of neighbors of a protein v is marked as Nv.  
From the topological view, two proteins are considered 
to be similar if they have more common immediate neigh-
bors in the network. Hence, for a pair of proteins (vi and vj) 
which connect each other in the protein interaction network, 
we calculate its similarity Simt(vi, vj) by using the following 
formula: 
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where w(vi, vj)=1 if the protein vi and the protein vj connect 
each other in the network.  
For a pair of proteins (vi and vj) which do not have any 
edges connecting them in the graph G, their similarity, 
marked as Simt*(vi, vj), is calculated by the following for-
mula:  
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where uk denotes the intermediate node on the shortest path 
from the protein vi to the protein vj. If there exist more than 
one shortest path for a pair of nodes vi and vj, all the shortest 
paths will be kept and the corresponding Simt*(vi, vj) will be 
calculated and the largest Simt*(vi, vj) will be kept. A sche-
matic drawing of a shortest path from vi to vj with n+1 hops 
is shown in Figure 1.  
Generally, the shortest path from a given protein vi to a 
target protein vj was calculated by computing its hops from 
vi to vj [36]. However, a path with the least hops may not be 
the true path. For example, as shown in Figure 2, there are 
three paths from the protein vi to the protein vj: path 1 (vi; v3; 
vj) with two hops, path 2 (vi; v1; v2; vj) with three hops, and 
path 3 (vi; v4; v5; v6; vj) with four hops. The weight in the 
figure denotes the reliability between two proteins. It will be 
path 1 if the shortest path is selected by hops. However, 
path 2 will be selected if we consider the reliability of the 
edges on the path. It is difficult to be reachable from vi to vj 
if path 1 with the unreliable edge (whose weight is 0.01 and 
which may be the false positive edge and not there actually) 
is selected.  
Hence, in our approach, for a pair of proteins we try to 
find the most reliable path between them. That means we 
must find the path with the highest continued product of 
edge weight by considering the “bucket effect”. To avoid 
enumeration of all the possible paths between vi and vj, we 
change the problem for calculating the continued product of 
edge weight for each path into the problem for finding a 
shortest path between vi and vj. 
To calculate the shortest path between a pair of two pro-
teins, we use 1/Simt(vi, vj) to describe the distance between 
two connected proteins vi and vj and reweight the edge (vi, vj) 
in the graph G. The shortest path is calculated by using the 
Dijkstra’s algorithm [52]. 
 
 
Figure 1  Schematic drawing of a shortest path from a protein vi to a 
protein vj with n+1 hops.  
 
Figure 2  An example of shortest path calculation with multiple paths 
from a protein vi to a protein vj. 
Take Figure 2 for example, the lengths of path 1, path 2 
and path 3 are 101.11 (1/0.9+1/0.01), 4.35 (1/0.6+1/0.8+ 
1/0.7), and 6.01(1/0.6+1/0.8+1/0.7+1/0.6), respectively. 
Hence, the shortest path between vi and vj is path 2 and it is 
the most reliable path among the three paths between vi and 
vj in Figure 2. Hence, the similarity of vi and vj is calculated 
by using path 2 not path 1 with the least hops.  
For a given disease d, let Sd denote the set of its known 
disease-causing genes. Then, for a new candidate gene vi, 
the probability that it is also such a disease-causing gene is 
evaluated by the sum of similarities between it and the 
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All the candidate genes are then ranked based on these 
scores. The complexity of calculating a candidate gene’s 
probability to be a disease-causing gene depends on the 
number of known disease-causing genes in Sd and the com-
plexity of computing the shortest paths. 
1.2  SPGOranker: integration of GO annotations into 
SPranker 
It has been shown that similarities among disorders imply 
involvement of functionally related gene products, which is 
generally summarized as “phenotypic overlap implies ge-
netic overlap”. Recent studies also showed that diseases 
with similar phenotypes often involve common molecular 
mechanisms and the functions of their corresponding dis-
ease-causing genes are generally similar.  
Franke’s work [53] shows that GO annotations are the 
most effective resources for the identification of dis-
ease-causing genes. Many other researchers also explored 
the relationship between the GO annotations and dis-
ease-causing genes and predicted new candidates by using 
their functional similarity to the known causal genes, such 
as G2D [54], POCUS [55], FP [56] and GFFST [57].  
The Gene Ontology project [58] provides a controlled 
vocabulary of terms for describing gene product character-
istics and gene product annotation data. The GO ontology is 
with a hierarchical structure and is generally described as a 
directed acyclic graph (DAG). There have been many com-
* 
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putational methods for calculating the similarity between 
GO terms [59,60]. In this paper, we used one of our previ-
ous methods in [59] to calculate the GO term similarity by 
taking into account the hierarchical organization of func-
tional annotations. For a given pair of proteins vi and vj, 
their functional similarity Simf(vi, vj) is defined as the max-
imum similarity of their corresponding GO terms, as shown 
in eq. (4): 
     
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where Ti and Tj are the corresponding sets of GO terms for 
the protein vi and the protein vj, respectively. The functional 
similarity, marked as goSim(c1,c2), between the term c1∈Ti 
and term c2∈Tj is calculated by using the method in [59]. 
For each species, there are three types of annotations: bi-
ological processes, cellular components and molecular 
functions. In this paper, the molecular functions are used to 
calculate the functional similarity between proteins and an 
improved algorithm SPGOranker is proposed to prioritize 
disease-causing genes by integrating the functional similar-
ity into SPranker. A parameter α is used to integrate the 
topological similarity and the functional similarity, as 
shown in eq. (5).  
        , , ,  * 1 * .t fi j i j i jSim v v a Sim v v a Sim v v    (5) 
The rest steps of SPGOranker are the same as those of 
SPranker. When α=1, only the topological similarity is con-
sidered and SPGOranker will degenerate into SPranker.  
2  Results and discussion 
2.1  Experimental data sources 
The human protein-protein interactions were downloaded 
from release 9 of the Human Protein Reference Database 
[61] with both redundant interactions and self-loops re-
moved. Finally, a protein interaction network with 9763 
genes and 37060 interactions was obtained and the un-
weighted network was used in our experiment. 
The ODs and causal gene information were downloaded 
from Orphanet [50]. Thereafter, we merged some of the OD 
sub-types of a single disease based on the disorder names 
described in [30,33]. In our work, we selected 172 ODs that 
have at least five causal genes. The 172 ODs contain 1598 
genes in total and 1063 OD-causing genes were found in the 
protein interaction network used in this paper.  
2.2  Cross-validation analysis 
To evaluate the performance of the proposed algorithms 
SPranker and SPGOranker for prioritizing disease-causing 
genes, we compared them with three state-of-the-art meth-
ods: RWR [33], ICN [35], and VS [36]. A leave-one-out 
cross-validation procedure was used to carry out the evalua-
tion. In each cross validation trial, one causal gene with an 
OD (“target gene”) from the data was removed, and each 
algorithm was evaluated by its success in assigning the rank 
to the “target gene”. For each validation trial, one seed gene 
(“target gene”) from 172 ODs was removed and mixed with 
99 genes selected randomly from the protein interaction 
network to form a set of 100 candidate genes. The remain-
ing seed genes are treated as the training set.  
SPranker, SPGOranker, ICN, VS, and RWR were ap-
plied to the test set for prioritizing OD-causing genes. In 
this paper, the default value of α in SPGOranker is set to be 
0.8. During each execution, the rank of the “target gene” 
was marked. The performance of each algorithm is evalu-
ated in terms of success rate with the respective rank cut-off 
(k). If the “target gene” is ranked among the top k in a par-
ticular validation trial, it is considered as a “success”. As 
what has been done in [36], we also used k ranging from 1 
to 30 in this paper. Validation trials are repeated until all the 
seed genes have been used as the target genes and their 
ranks are obtained. The “success rate” is defined as the ratio 
of successful validation trails and the total validation trails 
for all the existing OD genes from 172 ODs [36]. 
The results of the five algorithms SPranker, SPGOranker, 
ICN, VS, and RWR on the success rate with k ranging from 
1 to 30 are shown in Figure 3. When k=1, out of 1063 cases 
407 are achieved successfully by SPGOranker. SPranker 
and VS also achieve similar performance with a success rate 
of 37.8% (402/1063) and 37.1% (394/1063). The success 
rates of RWR and ICN are 35.9% (381/1063) and 32.7% 
(348/1063), respectively. From Figure 3 we can see that 
SPGOranker performs best consistently with k ranging from 
1 to 30, and SPranker also achieves a better result compared 
with ICN, VS, and RWR. These results imply the effec-
tiveness of SPranker for the prioritization of OD-causing 
genes and the integration of GO annotations contributes to 
the improvement of detecting true OD-causing genes.  
 
 
Figure 3 (color online)  Comparison of five prioritization algorithms, 
SPranker, SPGOranker, ICN, VS, and RWR, on the success rate with k 
ranging from 1 to 30. 
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To further investigate why and how SPranker and 
SPGOranker prioritize the disease-causing genes effectively, 
we analyze the intersection of disease-causing genes identi-
fied by the algorithms SPranker, SPGOranker, ICN, VS and 
RWR with k=1. The analysis results are shown in Table 1. 
As shown in Table 1, there are 323 disease-causing genes 
both identified by SPranker and by SPGOranker, which is 
about 80.3% of the true predictions by SPranker and by 
SPGOranker. Out of 394 disease-causing genes identified 
by VS, 309 genes (about 78.4%) are also discovered by 
SPGOranker and SPGOranker predicts 96 different true 
disease-causing genes. ICN identifies 348 disease-causing 
genes and about 77.0% are covered by SPGOranker. One 
hundred and thirty-seven different true disease-causing 
genes are predicted by SPGOranker, which is about 1.7 
times that identified by ICN. Out of 381 disease-causing 
genes predicted by RWR, 288 genes (about 75.6%) are also 
discovered by SPGOranker and SPGOranker predicts 117 
different true disease-causing genes.    
2.3  Analysis of the effect of parameter α 
In the above analysis, α=0.8 is used in SPGOranker. To 
analyze the effect of parameter α on the results, we change 
the value of α from 0.0 to 1.0 with 0.1 increments. When 
α=0.0, only GO information is used to calculate the similar-
ity between proteins. The analysis results are shown in Fig-
ure 4. 
Table 1  Contingency table of disease-causing genes identified by the 
algorithms SPranker, SPGOranker, ICN, VS and RWR with k=1 
 SPranker SPGOranker VS ICN RWR 
SPranker 402 323 309 268 287 
SPGOranker 323 405 309 268 288 
VS 309 309 394 264 285 
ICN 268 268 264 348 257 
RWR 287 288 285 257 381 
 
 
Figure 4 (color online)  Cross validation results with different values of 
the parameter α. 
From Figure 4 we can see that with the increase of rank 
cutoff k, the success rates also increase. For the same rank 
cutoff k, the success rates of SPGOranker also increase with 
the increase of α up to 0.6. For all the rank cutoff k=5, 10, 
15, 20, 25, 30, similar results are obtained by SPGOranker 
with α ranging from 0.6 to 0.8. There is a small decline for 
the success rate when α>0.8 is used. When α=1, a more 
clear decline for the success rate can be seen from Figure 4 
as SPGOranker has degenerated into SPranker. The analysis 
of parameter α’s effect shows that the topological similarity 
and the functional similarity have their own special contri-
butions to the prioritization of disease-causing genes. 
2.4  Predicting novel causing genes of 10 ODs 
The proposed algorithms SPranker and SPGOranker were 
applied on 172 ODs to predict potential novel OD-causing 
genes. We select ten ODs which are associated with more 
than 10 known valid causing genes and have known pro-
tein-protein interactions for all of their causing genes. The 
known OD causing genes are considered as seeds and the 
immediate neighbors of the known causing genes in the 
protein interaction network are considered as candidate dis-
ease genes. Taken the severe combined immunodeficiency 
(SCID) as case study, the top 10 candidate genes predicted 
by SPranker, SPGOranker, ICN, VS, and RWR are shown 
in Table 2.  
SCID is a genetic disorder characterized by the absence 
of functional T-lymphocytes. It is the most severe form of 
primary immunodeficiency. As shown in Table 2, the first 
predictions of SPranker and SPGOranker are both “ZAP70 
(zeta-chain-associated protein 70 kD)”, which is also identi-
fied by VS as the top 1. Though ZAP70 is not collected into 
Orphanet [50], recent research has shown that ZAP70 defi-
ciency is an autosomal recessive form of severe combined 
immune deficiency (SCID). Moreover, Pagon’s work [62] 
also shows that ZAP70 is signaling of abnormal T cell  
receptor, which is caused by cell-mediated immunodefi-
ciency.  
A new candidate gene “JAK1 (Janus kinase 1)” is identi-
fied as the second one both by SPranker and SPGOranker,  
Table 2  Top 10 predictions of severe combined immunodeficiency 
Rank SPranker SPGOranker ICN VS RWR 
1 ZAP70 ZAP70 1IL2RB ZAP70 STIM2 
2 JAK1 JAK1 TRAT1 JAK1 IPO5 
3 IL2RB STAT5A JAK1 STAT5A TRPC6 
4 STAT5A IL2RB ZAP70 TRB@ TRPC3 
5 CD3G PTPN6 PTPN22 CD3G XRCC4 
6 TRB@ CD3G STAT5A PTPN6 LIG4 
7 PTPN6 TRB@ PTPN6 IL2RB ACTB 
8 TRAT1 PTPN22 SHC1 PTPN22 GRB2 
9 TRA@ TRAT1 SYK TRA@ THBS1 
10 TSLP IL7 PIK3R1 TRAT1 FYN 
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Table 3  Ten ODs and their top 5 predictionsa) 
Disease name KN Method Top 5 predictions 
Retinitis pigmentosa 35 
SPranker RDH5, DHX30, SLC24A1, PRPH, FIZ1 
SPGOranker RDH5, DHX30, SLC24A1, FIZ1, PRPH 
Microdeletion syndrome 21 
SPranker FOXP4, FOXP1, SLC7A8, MEF2D, NKX2-5 
SPGOranker FOXP4, FOXP1, SLC7A8, MEF2D, NKX2-5 
Cone rod dystrophy 17 
SPranker CNGB1, CABP4, GUCA2B, NPHP4, ROM1 
SPGOranker CNGB1, CABP4, NPHP4, GUCA2B, ROM1 
Severe combined immunodeficiency 17 
SPranker ZAP70, JAK1, IL2RB, STAT5A, CD3G 
SPGOranker ZAP70, JAK1, STAT5A, IL2RB, PTPN6 
Fanconi anemia 15 
SPranker HES1, XRCC3, SAMD3, CYP19A1, RAD51 
SPGOranker HES1, XRCC3, RAD51, USP1, CYP19A1 
Zellweger syndrome 14 
SPranker PEX7, ABCD1, ABCD2, ABCD3, PXMP4 
SPGOranker ABCD1, ABCD2, PEX7, ABCD3, PEX11A 
Neonatal adrenoleukodystrophy 12 
SPranker PEX7, ABCD1, ABCD2, ABCD3, PXMP4 
SPGOranker ABCD1, ABCD2, PEX7, ABCD3, PXMP4 
Infantile Refsum disease 12 
SPranker PEX7, ABCD1, ABCD2, ABCD3, PXMP4 
SPGOranker ABCD1, ABCD2, PEX7, ABCD3, PXMP4 
Papillary or follicular thyroid carcinoma 11 
SPranker OCRL, TRIM28, RNF14, ZNF10, SHC1 
SPGOranker OCRL, TRIM28, RNF14, SHC1, GAB1 
Romano-Ward syndrome 11 
SPranker KCNE4, ALG10B, NDUFS6, ALG10, KCNJ3 
SPGOranker KCNE4, ALG10B, KCNJ3, NDUFS6, ALG10 
a) KN means the number of the known disease-causing genes in the corresponding OD. 
and “IL2RB” is listed as the third one by SPranker and the 
fourth one by SPGOranker. Russell’s study [63] shows that 
gene JAK1 and gene IL-2Rβ&γ interact with each other, 
and Ç chain mutations lead to X-linked severe combined 
immunodeficiency. In addition, “TSLP (thymic stromal 
lymphocytes)” was listed as the 10th one by SPranker, but 
did not appear at any top 10 list by any other four algo-
rithms. It has been shown that TSLP plays a role in control-
ling innate and adaptive immune responses [64].  
The top 5 predictions for each OD by SPranker and 
SPGOranker are shown in Table 3.  
3  Conclusion 
In this study, we proposed two algorithms SPranker and 
SPGOranker to prioritize disease-causing genes in protein 
interaction networks. SPranker is a simple localized algo-
rithm which only uses a protein interaction network. 
SPGOranker prioritizes candidates by considering both top-
ological similarity and functional similarity between the 
predicted candidates and the known disease-causing genes. 
The proposed algorithms SPranker and SPGOranker were 
applied to 1598 known orphan disease-causing genes 
(ODGs) from 172 orphan diseases (ODs) and compared 
with three state-of-the-art approaches, ICN, VS and RWR. 
The experimental results show that SPranker and 
SPGOranker outperform ICN, VS, and RWR for the priori-
tization of orphan disease-causing genes. Importantly, the 
top predictions of SPranker and SPGOranker for the severe 
combined immunodeficiency match the known literature, 
providing further investigation of several novel causal rela-
tionships. 
It is important to note that the performance of the pro-
posed algorithm SPranker will rely on the quality of the 
protein interaction network though the only usage of net-
work makes it simple and convenient to be used. For the 
algorithm SPGOranker, the combination of GO annotations 
improves its performance for the prioritization of dis-
ease-causing genes, but takes extra time to compute the GO 
term similarity and makes it more complex. Of course, the 
extra time costs are worthwhile. Moreover, only the molec-
ular functions are considered in this paper. In our future 
work, the biological processes, cellular components and 
other biological information will be further considered. 
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